(S)-2-(1-(2-(2-Methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid

Catalog No. :
ACJWVB412
CAS No. :
2128714-16-7
Molecular Formula :
C28H31N3O8S
Molecular Weight :
569.64

IUPAC Name:(S)-2-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid

(S)-2-(1-(2-(2-Methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$848.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(1-(2-(2-Methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid
IUPAC Name(S)-2-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid
Molecular FormulaC28H31N3O8S
Molecular Weight569.64
SMILESCOC(C=CC=C1)=C1[C@H](OC2CCOCC2)CN3C4=C(C(C)=C(C5=NC=CO5)S4)C(N(C3=O)C(C)(C)C(O)=O)=O
InChI KeyZZWWXIBKLBMSCS-HXUWFJFHSA-N
SynonymFirsocostat S enantiomer
CAS No.2128714-16-7

Synthetic Route by SureRoute

1. ACJWVB412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJWVB412 route product structure diagram
    ACJWVB4122128714-16-7
Inquiry

2. ACJWVB412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJWVB412 route product structure diagram
    ACJWVB4122128714-16-7
Inquiry

Comments (0)